U.S.-EU Partnership on GMP Inspections Adds Five Countries

Drug Industry Daily
The FDA has agreed to recognize drug and active pharmaceutical ingredient GMP inspections carried out by authorities in Belgium, Denmark, Finland, Latvia and Estonia, updating the 1998 mutual recognition agreement between the U.S. and the European Union.

To View This Article:


Subscribe To Drug Industry Daily